The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Splenic Marginal Zone Lymphoma: Diagnosis and Management

Indolent B-cell lymphoma with characteristic splenic involvement and varied treatment approaches

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →

What is Splenic Marginal Zone Lymphoma: Diagnosis and Management?

SMZL accounts for less than 1 percent of all non-Hodgkin lymphomas and approximately 20 percent of marginal zone lymphomas.

Classical features include splenomegaly, lymphocytosis with characteristic villous lymphocytes and characteristic immunophenotype.

Recurrent genetic alterations include 7q deletion, NOTCH2, KLF2, TP53 mutations and BCR signaling pathway alterations.

Hepatitis C virus association is well-recognized particularly in geographic regions with high HCV prevalence.

Diagnosis combines splenectomy or core biopsy with peripheral blood and bone marrow examination, immunophenotyping and molecular testing.

Symptoms

Asymptomatic disease in significant proportion of patients identified incidentally with cytopenias or splenomegaly.
Splenomegaly often progressive with abdominal discomfort, early satiety and rarely splenic infarction or rupture.
Cytopenias from splenic sequestration or autoimmune complications including immune thrombocytopenia, autoimmune hemolytic anemia.
Constitutional B symptoms with fever, night sweats and weight loss in approximately 25 percent of patients.
Lymphadenopathy is uncommon and minimal when present compared with other lymphomas.

Risk Factors

Older age with median age at diagnosis approximately 65 to 70 years.
Hepatitis C virus chronic infection particularly in endemic regions.
Autoimmune diseases including Sjögren syndrome and other connective tissue disorders.
Family history of B-cell lymphoproliferative disorders.
No clearly established environmental risk factors beyond HCV association.

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Unexplained splenomegaly with lymphocytosis warrants hematology evaluation and lymphoma workup.
  • Cytopenias with associated splenomegaly require comprehensive evaluation including bone marrow examination.
  • Patients with HCV infection and lymphoproliferative findings need combined hepatology and hematology assessment.
  • Patients with established SMZL showing progression with worsening cytopenias, splenic enlargement or constitutional symptoms need reassessment.
  • Long-term hematologic follow-up is essential given indolent disease course with potential for transformation.

Treatment Methods

01
Watchful waiting for asymptomatic patients with stable cytopenias and absence of progressive symptoms is appropriate.
02
Hepatitis C antiviral therapy with direct-acting agents may produce lymphoma response in HCV-associated cases.
03
Splenectomy provides effective disease control for symptomatic splenomegaly or cytopenias.
04
Rituximab monotherapy or rituximab combined with chemotherapy for symptomatic disease requiring systemic treatment.
05
Comprehensive care including HCV testing and treatment when relevant, vaccination for splenectomy patients, monitoring for transformation, individualized treatment selection based on patient factors and ongoing surveillance optimize long-term outcomes in this indolent disease.

Which Department to Visit?

You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Hematoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.